PUBLISHED DATE: 2025-08-11 23:16:38

VIDEO TRANSCRIPT:

SPEAKER:

I think our primary prediction or our thesis is there's just going to be more convergence, right? From a company standpoint, it looks like consolidation, but from a consumer perspective, it really just looks like more things being offered by the companies and brands that I know and trust. One of the great elements of the retail health setting is they're often connecting through or have a strong role through pharmacy and through the medicines themselves. We are excited about places where there's an opportunity to build off of that, to not just say dispense or fulfill a medication, but then also advise or build elements that are connected to that. One of the challenges is knowing the person you're reaching out to. The concept of identity management is in some cases a technical thing, but really what it comes down to is do we know the person we're talking to? We've all gone through those places where you check the boxes of what I'm willing to receive or get or what we call kind of consent management. But then further is actually maybe unstated. I actually like the long form science stuff. You can send me more of that. And that's a hard thing for me to observe or stage, or there's probably not even many places to even state that to these retail health companies. But that's a thing that we're trying to encourage our clients to think about. How do they capture and manage and take advantage of some of those preferences so that they know how to communicate with each member or each potential consumer in a different way? In a few of the major retail health players, they have different business units that are connected to say home health or clinical care or other elements of really care provision beyond the kind of traditional retail business they're known for. We'd like to see and we're trying to work with them in many settings to integrate those further so that they're not just sort of a holding company strategy but an integrated experience strategy. And in many cases that is still to come, but a big piece of how we think these companies will break out in the year ahead.